Stability Study Design – Bracketing and Matrixing Webinar

Attend our live webinar: ‘Stability Study Design – Bracketing and Matrixing’ with guest speaker Dr. Mark Powell.

Stability Study Design – Bracketing and Matrixing

Stability programmes are a costly undertaking, especially for products that have multiple strengths and packaging configurations, where a full study design will require every configuration to be evaluated for three registration batches at each time point.

The use of reduced study designs such as bracketing and matrixing can reduce the cost of formal stability studies. This webinar describes when the use of such approaches is allowable, together with their associated benefits and risks.

To outline the benefits and risks of this approach we are hosting a webinar with guest speaker Mark Powell from Mark Powell Scientific Limited on ‘Stability Study Design – Bracketing and Matrixing’.

Join us on Wednesday 12 August 2020 at 2pm.
Q1 Scientific Webinar - Stability Study Design – Bracketing and Matrixing with Dr. Mark Powell

In this webinar you will learn about:

  • Bracketing and Matrixing Designs (ICH Q1D)
  • Bracketing study designs
  • Bracketing study risks
  • Matrix study designs
  • Matrix study risks
  • Combined bracketing and matrix study designs
  • The risks and benefits

At the end of the webinar there will be a Q&A session with Dr. Mark Powell, where you will have the opportunity to ask some specific questions.

REGISTER NOW

About the speaker Dr. Mark Powell

Dr. Mark Powell is a Fellow of the Royal Society of Chemistry (RSC) with over thirty years’ experience as a Senior Analytical Chemist.Dr Mark Powell

Mark has served as both Honorary Secretary and Honorary Treasurer of the RSC’s Analytical Division and led a working group on continuing professional development until July 2016.  He has worked at a senior level in a number of companies with responsibility for analytical development and equipment qualification.  In 2010 Mark was appointed Scientific Manager of a UK-based pharmaceutical CRO, with responsibility for guiding the direction of drug development programmes as well as establishing collaborations with academia and instrument manufacturers.

In 2013, he set up his own company to provide training and consultancy services to the pharmaceutical industry.  His consultancy work has involved, amongst other things, managing the analytical aspects of pharmaceutical development programmes and conducting data integrity audits.  He is in demand as a trainer in topics such as pharmaceutical development, chromatography, spectroscopy, dissolution testing, data integrity, control of impurities, technical writing, stability/stress studies and sample preparation.

Register now

To register for this webinar today, please visit our webinar registration page.